Basic information

Biomarker: Hsa-miR-155

Histology type: endometrial carcinoma

Cohort characteristics

Country: China

Region: Hunan

Study type: prospective study

Followed up time :

Subgroup 1 name : EC

Subgroup 1 number: 44

Subgroup 2 name: Healthy controls

Subgroup 2 number: 12

Total number Group I Group I number Group II Group II number Group III Group III number Group IV Group IV number
56 EC 44 health 12

Sample information

Description: Hsa-miR-155 may play an important role in the proliferation, and metastasis of endometrial cancer, which may be a indicator in the diagnosis and prognosis of endometrial cancer and may be used as a predictive biomarker.

Sample type : serum

Sample method: Real time quantity PCR

Disease information

Related information

HGNC miRNA approved symbol: MIR155

HGNC miRNA approved name: microRNA 155

HGNC miRNA locus type: RNA, micro

HGNC miRNA symbol status: Approved

HGNC miRNA ID: HGNC:31542

HGNC miRNA link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:31542

Stem loop sequence symbol: hsa-mir-155

Stem loop sequence accession: MI0000681

Stem loop sequence gene family: MIPF0000157

Stem loop sequence annotation confidence: high

Mature sequence symbol: hsa-miR-155-5p$ hsa-miR-155-3p

Mature sequence accession: MIMAT0000646$ MIMAT0004658

Previous IDs: hsa-miR-155$hsa-miR-155*

Evidence: experimental; cloned [PMID:15325244,PMID:17604727,PMID:17616659,PMID:17989717],experimental; cloned [PMID:17604727]

miRBase link: https://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000681

Visulization